C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J
HoldCIN Rating 58/100How is this calculated?

Tilray's FY26: EBITDA Up, Cash Burn Still the Call

Tilray posted fiscal 2026 revenue of $915.454M and adjusted EBITDA of $61.139M but negative free cash flow of $98.624M; fiscal 2027 guidance and DEA timing create asymmetric read-throughs for U.S. MSOs and ancillaries.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.